| 000 | 01316nam a2200301 a 4500 | ||
|---|---|---|---|
| 005 | 20250914133909.0 | ||
| 008 | 040521s2003 sz i000 0 eng d | ||
| 020 |
_a9241209143 _cRM112.16 |
||
| 039 | 9 |
_a200509261548 _bwmeriam _y05-21-2004 _zfaizah |
|
| 060 | _aQV55 | ||
| 090 | _aQV55.S464 2003 who | ||
| 245 | 0 | 3 |
_aThe selection and use of essential medicines : _breport of the WHO Expert Commettee, 2002 (including the 12th Model List of Essential Medicines) / _cWHO Expert Committee on the Selection and Use of Essential Medicines _n(12th : _d2002 : _cGeneva, Switzerland) |
| 246 | 3 | 0 | _a12th model list of essential medicines |
| 260 |
_aGeneva, Switzerland : _bWorld Health Organization, _c2003 |
||
| 300 |
_avi, 126 p. ; _c24 cm. |
||
| 440 | 0 |
_aWHO Technical Report Series _v914 |
|
| 650 | 2 |
_aDrugs, Essential _xstandards |
|
| 650 | 2 |
_aFormularies _xstandards |
|
| 650 | 2 | _aDrug Utilization | |
| 650 | 2 |
_aDrug Information Services _xorganisation and administration |
|
| 710 | 2 | _aWorld Health Organization, Expert Committee on the Selection and Use of Essential Medicines | |
| 907 |
_a.b13381052 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQV55.S464 2003 who |
||
| 914 | _avtls003289776 | ||
| 991 | _aJabatan Bioperubatan | ||
| 998 |
_ad _b2004-08-05 _cm _da _feng _gsz _y0 _z.b13381052 |
||
| 999 |
_c337447 _d337447 |
||